AMERICAN BOARD OROFACIAL PAIN

Brand	Owner	Address	Description
ABOP	American Board of Orofacial Pain	1258 Berans Road Owings Mills MD 21117	AMERICAN BOARD OF OROFACIAL PAIN;Testing, analysis and evaluation of dentists' level of expertise to determine conformity with certification standards; Testing, analysis, and evaluation of the knowledge, skills and abilities of dentists in the field of orofacial pain to determine conformity with certification standards; Testing, analysis, and evaluation of competency in the field of orofacial pain to determine conformity with certification standards; Identifying minimal competency of dentists in the field of orofacial pain to determine conformity with certification standards; Certifying dentists for the status of diplomate; Certifying dentists based on minimal competency in the field of orofacial pain;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The invention provides isolated polynucleotide molecules, including plasmids; viral vectors; and transfected host cells that comprise a DNA sequence encoding an infectious RNA sequence encoding a North American PRRS virus; and also North American PRRS viruses encoded thereby. The invention further provides isolated infectious RNA molecules encoding a North American PRRS virus. The invention also provides isolated polynucleotide molecules, infectious RNA molecules, viral vectors, and transfected host cells encoding genetically-modified North American PRRS viruses; and genetically-modified North American PRRS viruses encoded thereby. The invention also provides vaccines comprising such plasmids, RNA molecules, viral vectors, and North American PRRS viruses, and methods of using these vaccines in swine and in other animals. Also provided are isolated polynucleotide molecules, viral vectors, and transfected host cells that comprise a nucleotide sequence encoding a peptide of a North American PRRS virus. These viral vectors and transfected host cell lines are useful in providing peptides to compensate for mutated peptide coding sequences of DNA sequences encoding genetically-modified North American PRRS viruses so that functional virions can be generated.